{{Rsnum
|rsid=9378805
|Chromosome=6
|position=417727
|Orientation=plus
|GMAF=0.3306
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 27.4 | 51.3 | 21.2
| HCB | 54.4 | 38.2 | 7.4
| JPT | 51.3 | 43.4 | 5.3
| YRI | 95.2 | 4.8 | 0.0
| ASW | 66.7 | 28.1 | 5.3
| CHB | 54.4 | 38.2 | 7.4
| CHD | 44.0 | 45.9 | 10.1
| GIH | 31.7 | 50.5 | 17.8
| LWK | 94.5 | 5.5 | 0.0
| MEX | 25.9 | 55.2 | 19.0
| MKK | 78.2 | 19.2 | 2.6
| TSI | 23.5 | 52.9 | 23.5
| HapMapRevision=28
}}

[http://www.newswise.com/articles/view/551128/ news] Slager and colleagues validated these in an independent sample of patients. The strongest association for chronic Lymphocytic Leukemia (CLL) was for [[rs735665]] on 11q24, where the risk was 50 percent higher. This was closely followed by a 39 percent increased risk associated with [[rs9378805]] on 6p25. Note: this is not a published paper - this is a report of a conference presentation.

{{omim
|desc=LEUKEMIA, CHRONIC LYMPHOCYTIC SUSCEPTIBILITY TO, 4
|id=612558
|rsnum=9378805
}}

{{PMID Auto
|PMID=20332261
|Title=Genetic Susceptibility Variants for Chronic Lymphocytic Leukemia
|OA=1
}}

{{PMID Auto GWAS
|PMID=21131588
|Trait=None
|Title=Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL
|RiskAllele=C
|Pval=0.000002
|OR=1.3800
|ORtxt=[1.20-1.58]
|OA=1
}}

{{PMID Auto
|PMID=19619313
|Title=An assessment of the portability of ancestry informative markers between human populations.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}